Could Cannabis Trigger Psychosis by Disrupting Glutamate Brain Pathways?
A review proposes that cannabis may trigger schizophrenia-like psychosis in genetically vulnerable individuals by disrupting glutamate neuronal connectivity, particularly in the brain's default mode network.
Quick Facts
What This Study Found
The review synthesizes three lines of evidence: cannabis is associated with psychosis in a subset of users, glutamate dysregulation is a feature of schizophrenia, and cannabis affects the glutamate system. The authors hypothesize that cannabis perturbs glutamate neuronal connectivity in the brains of genetically high-risk individuals, potentially initiating psychosis.
Key Numbers
Most cannabis users are unaffected; a portion develop acute psychotic symptoms; in some, symptoms continue after cessation; review proposes combining MRS and fMRI to test the glutamate hypothesis.
How They Did This
Narrative review examining the intersection of cannabis-psychosis associations, glutamate abnormalities in schizophrenia, and cannabis effects on glutamate pathways, proposing a testable hypothesis using combined MRS and fMRI.
Why This Research Matters
Despite strong epidemiological evidence linking cannabis and psychosis, the biological mechanism remains unclear. This review proposes a specific, testable mechanism (glutamate disruption in the default mode network) that could be verified with existing brain imaging technology.
The Bigger Picture
Schizophrenia research has increasingly moved beyond the dopamine hypothesis to include glutamate dysfunction. This review places cannabis at the intersection of these two systems, suggesting that cannabis may trigger psychosis through glutamate pathways rather than (or in addition to) direct dopamine effects.
What This Study Doesn't Tell Us
Narrative review with a proposed hypothesis that has not yet been tested. Selective citation of supporting evidence. The glutamate-cannabis-psychosis connection remains speculative. Does not account for all potential mechanisms of cannabis-related psychosis.
Questions This Raises
- ?Would MRS studies show glutamate differences between cannabis-using and non-using psychosis patients?
- ?What genetic variants determine vulnerability to cannabis-induced glutamate disruption?
- ?Could glutamate-targeting interventions prevent cannabis-related psychosis in high-risk individuals?
Trust & Context
- Key Stat:
- Cannabis may trigger psychosis through glutamate disruption, not just dopamine effects
- Evidence Grade:
- Moderate: Integrates multiple lines of evidence into a testable hypothesis, though the specific mechanism proposed has not yet been experimentally validated.
- Study Age:
- Published in 2025.
- Original Title:
- The Relationship of glutamate signaling to cannabis use and schizophrenia.
- Published In:
- Current opinion in psychiatry, 38(3), 177-181 (2025)
- Authors:
- Niznikiewicz, Margaret(2), Lin, Alexander, DeLisi, Lynn E(2)
- Database ID:
- RTHC-07261
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is glutamate and why does it matter?
Glutamate is the brain's main excitatory neurotransmitter, essential for learning, memory, and neural communication. Abnormal glutamate signaling has been found in schizophrenia, and this review suggests cannabis may worsen these abnormalities in people already genetically prone to psychosis.
Why do only some cannabis users develop psychosis?
The authors suggest that genetic vulnerability determines who is affected. In people without genetic predisposition, cannabis may perturb glutamate without lasting consequences. In those with genetic high risk, the same disruption could initiate a cascade leading to persistent psychosis.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-07261APA
Niznikiewicz, Margaret; Lin, Alexander; DeLisi, Lynn E. (2025). The Relationship of glutamate signaling to cannabis use and schizophrenia.. Current opinion in psychiatry, 38(3), 177-181. https://doi.org/10.1097/YCO.0000000000001003
MLA
Niznikiewicz, Margaret, et al. "The Relationship of glutamate signaling to cannabis use and schizophrenia.." Current opinion in psychiatry, 2025. https://doi.org/10.1097/YCO.0000000000001003
RethinkTHC
RethinkTHC Research Database. "The Relationship of glutamate signaling to cannabis use and ..." RTHC-07261. Retrieved from https://rethinkthc.com/research/niznikiewicz-2025-the-relationship-of-glutamate
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.